# NMB Therapeutics, Inc — Form D

NMB Therapeutics, Inc of HEMPSTEAD, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-06. The offering totals $200K, of which $60K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-10-06
- Form: D
- Accession: 0001886659-21-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $200K
- Amount sold: $60K
- Remaining: $140K
- Investors: 1
- Date of first sale: 2021-09-27
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-415938

## Issuer

- Name: NMB Therapeutics, Inc
- CIK: 0001886659
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Address: 395 WESTBURY BLVD, HEMPSTEAD, NY, 11550
- Phone: 6466448760

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Melvin Ehrlich | Director | Roslyn Harbor, NY |
| Daniel Fisher | Director | Pleasant Hill, CA |
| Melvin Ehrlich | Executive Officer | Roslyn Harbor, NY |
| Daniel Fisher | Executive Officer | Pleasant Hill, CA |
| Murray Froikin | Executive Officer | New York, NY |

## More

- [CIK 1886659 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1886659&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001886659-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.